Company Search:
Advanced Search
Sponsored Links
Tty Biopharm Company Limited Company Snapshot
Tty Biopharm Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tty Biopharm Company Limited with three other companies in this sector in Taiwan: Formosa Laboratories, Inc (2017 sales of 2.54 billion Taiwanese Dollars [US$82.35 million] of which 100% was Active Pharmaceutical Ingredient), Tci Co Ltd (4.07 billion Taiwanese Dollars [US$132.06 million] of which 65% was Asia), and Pharmally International Holding Company Ltd (4.30 billion Taiwanese Dollars [US$139.60 million] of which 42% was Glass Bottle).

Sales Analysis. Tty Biopharm Company Limited reported sales of 4.08 billion Taiwanese Dollars (US$132.27 million) for the year ending December of 2017. This represents an increase of 8.5% versus 2016, when the company's sales were 3.76 billion Taiwanese Dollars. This was the third consecutive year of growth at Tty Biopharm Company Limited. The sales level in 2017 was fairly close to the level five years ago: in 2012, Tty Biopharm Company Limited had sales of 4.02 billion Taiwanese Dollars. Sales of Anti-Infection Drug saw an increase that was more than double the company's growth rate: sales were up 58.2% in 2017, from 508.11 million Taiwanese Dollars to 803.70 million Taiwanese Dollars. Not all segments of Tty Biopharm Company Limited experienced an increase in sales in 2017: sales of Other fell 26.0% to 12.64 million Taiwanese Dollars. (However, this segment's sales were only a very small portion of the company's overall sales). Tty Biopharm Company Limited also experienced decreases in sales in Cardiovascular and Gastrointestinal Drug (down 1.3% to 486.28 million Taiwanese Dollars) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tty Biopharm Company Limited
  Stock Performance Chart for Tty Biopharm Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 81.40
(Figures in Taiwanese Dollars)
1 Week n/a   13 Weeks 3.6%  
4 Weeks -2.2%   52 Weeks -16.7%  
Tty Biopharm Company Limited Key Data:
  Ticker: 4105 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 4,078,760,000
(Year Ending Jan 2018).
Employees: N/A
  Currency: Taiwanese Dollars Market Cap: 20,240,110,000
  Fiscal Yr Ends: December Shares Outstanding: 248,650,000
  Share Type: Gu Closely Held Shares: 48,272,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.